As of June 21, 2025, Aphria Inc (APHA.TO) reports a Forward P/E of N/A.
Forward P/E gauges the price investors pay for each dollar of anticipated earnings, offering insight into a stock's future valuation.
Comparing Aphria Inc's Forward P/E to Peers
To better understand Aphria Inc's position, it's useful to compare its Forward P/E against industry peers. Below are selected comparisons:
| Company | Forward P/E |
|---|---|
| Aphria Inc (APHA.TO) | - |
| Corcept Therapeutics Inc (CORT) | 50.21 |
| Innoviva Inc (INVA) | 31.71 |
| Green Thumb Industries Inc (GTII.CN) | 22.68 |
| Supernus Pharmaceuticals Inc (SUPN) | 19.05 |
| Phibro Animal Health Corp (PAHC) | 11.35 |
Compared to its competitors, Aphria Inc's Forward P/E is difficult to compare due to insufficient data.